Recombinant Human LILRB3/CD85a/ILT5 Fc Chimera Protein, CF
Description
Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 95-105 kDa, reducing conditions. MW (theoretical): 72.6 kDa (monomer). The Recombinant Human LILRB3/CD85a/ILT5 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human LILRB3/CD85a/ILT5 Fc Chimera Protein has been validated for the following applications: Binding Activity.
Size
50 ug
Concentration
n/a
Applications
Binding Activity
Other Names
CD85 antigen-like family member A, CD85a, CD85a antigen, HL9Immunoglobulin-like transcript 5, ILT5, ILT-5, ILT5CD85a, Leukocyte immunoglobulin-like receptor 3, leukocyte immunoglobulin-like receptor subfamily B member 3, leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), LIR3, LIR3CD85A, LIR-3MGC138403, member 3, Monocyte inhibitory receptor HL9, PIRB